Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.

This study is a pharmacoepidemiologic description of pediatric bortezomib use. Exposure was identified through billing codes in patients admitted to US children's hospitals that participated with the Pediatric Health Information System between 2004 and 2013. Associated information on underlying...

Full description

Saved in:
Bibliographic Details
Main Authors: Amanda M DiNofia, Elizabeth Salazar, Alix E Seif, Yimei Li, Yuan-Shung Vera Huang, Rochelle Bagatell, Brian T Fisher, Richard Aplenc
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0151362&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850188968027488256
author Amanda M DiNofia
Elizabeth Salazar
Alix E Seif
Yimei Li
Yuan-Shung Vera Huang
Rochelle Bagatell
Brian T Fisher
Richard Aplenc
author_facet Amanda M DiNofia
Elizabeth Salazar
Alix E Seif
Yimei Li
Yuan-Shung Vera Huang
Rochelle Bagatell
Brian T Fisher
Richard Aplenc
author_sort Amanda M DiNofia
collection DOAJ
description This study is a pharmacoepidemiologic description of pediatric bortezomib use. Exposure was identified through billing codes in patients admitted to US children's hospitals that participated with the Pediatric Health Information System between 2004 and 2013. Associated information on underlying diseases, demographics, institutional use, mortality, and physician type was collected. Exposure to bortezomib was identified in 314 patients. Hematologist/Oncologists prescribed half of the bortezomib used. Use increased during the study period. Inpatient volume was positively correlated with bortezomib utilization. Bortezomib use in pediatrics is increasing for a variety of diseases. Variation in use exists across institutions. Further studies are needed to characterize bortezomib's efficacy in pediatric diseases.
format Article
id doaj-art-65416665e0d44d1eaaef64b46cca672b
institution OA Journals
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-65416665e0d44d1eaaef64b46cca672b2025-08-20T02:15:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015136210.1371/journal.pone.0151362Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.Amanda M DiNofiaElizabeth SalazarAlix E SeifYimei LiYuan-Shung Vera HuangRochelle BagatellBrian T FisherRichard AplencThis study is a pharmacoepidemiologic description of pediatric bortezomib use. Exposure was identified through billing codes in patients admitted to US children's hospitals that participated with the Pediatric Health Information System between 2004 and 2013. Associated information on underlying diseases, demographics, institutional use, mortality, and physician type was collected. Exposure to bortezomib was identified in 314 patients. Hematologist/Oncologists prescribed half of the bortezomib used. Use increased during the study period. Inpatient volume was positively correlated with bortezomib utilization. Bortezomib use in pediatrics is increasing for a variety of diseases. Variation in use exists across institutions. Further studies are needed to characterize bortezomib's efficacy in pediatric diseases.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0151362&type=printable
spellingShingle Amanda M DiNofia
Elizabeth Salazar
Alix E Seif
Yimei Li
Yuan-Shung Vera Huang
Rochelle Bagatell
Brian T Fisher
Richard Aplenc
Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
PLoS ONE
title Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
title_full Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
title_fullStr Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
title_full_unstemmed Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
title_short Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States.
title_sort bortezomib inpatient prescribing practices in free standing children s hospitals in the united states
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0151362&type=printable
work_keys_str_mv AT amandamdinofia bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT elizabethsalazar bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT alixeseif bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT yimeili bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT yuanshungverahuang bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT rochellebagatell bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT briantfisher bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates
AT richardaplenc bortezomibinpatientprescribingpracticesinfreestandingchildrenshospitalsintheunitedstates